Home
|
Learning Center
|
中文版
Publications
站内成果搜索:
搜索
Atorvastatin and pitavastatin reduce oxidative stress and improve IR/LDL-R signals in Alzheimer's disease
Atorvastatin: an efficient step forward in mesenchymal stem cell therapy of diabetic retinopathy
Atorvastatin improves erectile dysfunction in patients initially irresponsive to Sildenafil by the activation of endothelial nitric oxide synthase
Atorvastatin attenuates IL-6 production partly via activating heme oxygenase-1 in LPS-stimulated RAW264.7 macrophages
Atorvastatin Improves Inflammatory Response in Atherosclerosis by Upregulating the Expression of GARP
Atorvastatin ameliorates myocardial ischemia/reperfusion injury through attenuation of endoplasmic reticulum stress-induced apoptosis
Atorvastatin acutely reduces the reactivity to spasmogens in rat aorta: implication of the inhibition of geranylgeranylation and MYPT-1 phosphorylation
Atorvastatin attenuates atherosclerotic plaque destabilization by inhibiting endoplasmic reticulum stress in hyperhomocysteinemic mice
Atorvastatin prevents advanced glycation end products (AGEs)-induced cardiac fibrosis via activating peroxisome proliferator-activated receptor gamma (PPAR-gamma)
Atorvastatin Protects NSC-34 Motor Neurons Against Oxidative Stress by Activating PI3K, ERK and Free Radical Scavenging
Atorvastatin blocks increased L-type Ca2+ current and cell injury elicited by angiotensin II via inhibiting oxide stress
Atorvastatin-cyclodextrin systems: Physiochemical and biopharmaceutical evaluation
Atorvastatin ameliorates early brain injury after subarachnoid hemorrhage via inhibition of AQP4 expression in rabbits
Atorvastatin enhances angiogenesis to reduce subdural hematoma in a rat model
Atorvastatin May Correct Dyslipidemia in Adult Patients at Risk for Alzheimer's Disease Through an Anti-Inflammatory Pathway
Atorvastatin reduced soluble receptors of TNF-alpha in systemic lupus erythematosus
Atorvastatin improves pathological changes in the aged kidney by upregulating peroxisome proliferator-activated receptor expression and reducing matrix metalloproteinase-9 and transforming growth factor-beta 1 levels
Atorvastatin Inhibits Myocardial Apoptosis in a Swine Model of Coronary Microembolization by Regulating PTEN/PI3K/Akt Signaling Pathway
Atorvastatin restricts HIV replication in CD4(+) T cells by upregulation of p21
Atorvastatin for the Prophylaxis of Acute Graft-versus-Host Disease in Patients Undergoing HLA-Matched Related Donor Allogeneic Hematopoietic Stem Cell Transplantation (allo-HCT)
Atorvastatin calcium loaded PCL nanoparticles: development, optimization, in vitro and in vivo assessments
Atorvastatin in improvement of cognitive impairments caused by amyloid beta in mice: involvement of inflammatory reaction
Atorvastatin up-regulates the expression and activity of renal Cytochrome P450 3A2 in diabetic rats
Atorvastatin Prevents Neuroinflammation in Chronic Constriction Injury Rats through Nuclear NF kappa B Downregulation in the Dorsal Root Ganglion and Spinal Cord
Atorvastatin treatment increases plasma bilirubin but not HMOX1 expression in stable angina patients
Atorvastatin Increases miR-124a Expression: A Mechanism of Gamt Modulation in Liver Cells
Atorvastatin Treatment for Carotid Intima-Media Thickness in Chinese Patients With Type 2 Diabetes A Meta-Analysis
Atorvastatin attenuates cognitive deficits through Akt1/caspase-3 signaling pathway in ischemic stroke
Atorvastatin Prevents Cognitive Deficits Induced by Intracerebroventricular Amyloid-beta(1-40) Administration in Mice: Involvement of Glutamatergic and Antioxidant Systems
Atorvastatin Reduces the Incidence of Postoperative Atrial Fibrillation in Statin-Naive Patients Undergoing Isolated Heart Valve Surgery: A Double-Blind, Placebo-Controlled Randomized Trial
Atorvastatin Ameliorates Radiation-Induced Cardiac Fibrosis in Rats
Atorvastatin-induced dermatomyositis in a 47-year-old woman with Sjogren's syndrome
Atorvastatin protects endothelial colony-forming cells against H2O2-induced oxidative damage by regulating the expression of annexin A2
Atorvastatin and sildenafil decrease vascular TGF-beta levels and MMP-2 activity and ameliorate arterial remodeling in a model of renovascular hypertension
Atorvastatin Regulates Apoptosis in Chronically Ischemic Myocardium
Atorvastatin in combination with inhaled beclometasone modulates inflammatory sputum mediators in smokers with asthma
Atorvastatin and prevention of contrast induced nephropathy following coronary angiography
Atorvastatin improves Y-maze learning behaviour in nicotine treated male albino rats
Atorvastatin alleviates experimental diabetic cardiomyopathy by suppressing apoptosis and oxidative stress
Atorvastatin causes regression of endometriotic implants in a rat model
Atorvastatin pretreatment diminishes the levels of myocardial ischemia markers early after CABG operation: an observational study
Atorvastatin treatment lowers fasting remnant-like particle cholesterol and LDL subfraction cholesterol without affecting LDL size in type 2 diabetes mellitus: Relevance for non-HDL cholesterol and apolipoprotein B guideline targets
Atorvastatin or transgenic expression of TFPI inhibits coagulation initiated by anti-nonGal IgG binding to porcine aortic endothelial cells
Atorvastatin has antithrombotic effects in patients with type 1 diabetes and dyslipidemia
Atorvastatin-induced modulation of monocyte respiratory burst in vivo in patients with IgA nephropathy: a chronic inflammatory kidney disease
Atorvastatin: safety and tolerability
Atorvastatin-induced cell toxicity in yeast is linked to disruption of protein isoprenylation
Atorvastatin increases expression of low-density lipoprotein receptor mRNA in human circulating mononuclear cells
Atorvastatin therapy reduces interferon-regulated chemokine CXCL9 plasma levels in patients with systemic lupus erythematosus
Atorvastatin inhibits inflammatory angiogenesis in mice through down regulation of VEGF, TNF-alpha and TGF-beta 1
Atorvastatin prevents hippocampal cell death, neuroinflammation and oxidative stress following amyloid-beta(1-40) administration in mice: Evidence for dissociation between cognitive deficits and neuronal damage
Atorvastatin decreases serum levels of advanced glycation endproducts (AGEs) in nonalcoholic steatohepatitis (NASH) patients with dyslipidemia: clinical usefulness of AGEs as a biomarker for the attenuation of NASH
Atorvastatin inhibits oxidative stress via adiponectin-mediated NADPH oxidase down-regulation in hypercholesterolemic patients
Atorvastatin Inhibits gp91(phox) Circulating Levels in Patients With Hypercholesterolemia
Atorvastatin-Induced Prolonged Cholestasis with Bile Duct Damage
Atorvastatin Downregulates Monocyte CD36 Expression, Nuclear NF kappa B and TNF alpha Levels in Type 2 Diabetes
Atorvastatin upregulates nitric oxide synthases with Rho-kinase inhibition and Akt activation in the kidney of spontaneously hypertensive rats
Atorvastatin affects TLR4 clustering via lipid raft modulation
Atorvastatin attenuates hepatic fibrosis in rats after bile duct ligation via decreased turnover of hepatic stellate cells
Atorvastatin pretreatment augments the effect of metformin in patients with polycystic ovary syndrome (PCOS)
Atorvastatin Induces Apoptosis In Vitro and Slows Growth of Tumor Xenografts but Not Polyp Formation in Min Mice
Atorvastatin reduces proteinuria in non-diabetic chronic kidney disease patients partly via lowering serum levels of advanced glycation end products (AGEs)
Atorvastatin attenuates post-implant tissue degeneration of cardiac prosthetic valve bovine pericardial tissue in a subcutaneous animal model
Atorvastatin Improves Survival in Septic Rats: Effect on Tissue Inflammatory Pathway and on Insulin Signaling
Atorvastatin Combined To Interferon to Verify the Efficacy (ACTIVE) in relapsing-remitting active multiple sclerosis patients: a longitudinal controlled trial of combination therapy
Atorvastatin attenuates murine anti-glomerular basement membrane glomerulonephritis
Atorvastatin restores the balance between pro-inflammatory and anti-inflammatory mediators in rats with acute myocardial infarction
Atorvastatin for Diabetic Macular Edema in Patients With Diabetes Mellitus and Elevated Serum Cholesterol
Atorvastatin improves the response to sildenafil in hypercholesterolemic men with erectile dysfunction not initially responsive to sildenafil
Atorvastatin treatment affects atrial ion currents and their tachycardia-induced remodeling in rabbits
Atorvastatin enhances kainate-induced gamma oscillations in rat hippocampal slices
Atorvastatin attenuates p-cresyl sulfate-induced atherogenesis and plaque instability in ApoE knockout mice
Atorvastatin partially inhibits the epithelial-mesenchymal transition in A549 cells induced by TGF-beta 1 by attenuating the upregulation of SphK1
Atorvastatin attenuates TNBS-induced rat colitis: the involvement of the TLR4/NF-kB signaling pathway
Atorvastatin attenuates sympathetic hyperinnervation together with the augmentation of M2 macrophages in rats postmyocardial infarction
Atorvastatin Prevents Glutamate Uptake Reduction Induced by Quinolinic Acid Via MAPKs Signaling
Atorvastatin attenuates the antinociceptive tolerance of morphine via nitric oxide dependent pathway in male mice
Atorvastatin for Prevention of Amikacin-induced Electrolytes Imbalances; a Randomized Clinical Trial
Atorvastatin attenuation of ABCB1 expression is mediated by microRNA miR-491-3p in Caco-2 cells
Atorvastatin ameliorates cognitive impairment, A beta 1-42 production and Tau hyperphosphorylation in APP/PS1 transgenic mice
Atorvastatin ameliorates endothelium-specific insulin resistance induced by high glucose combined with high insulin
Atorvastatin and Fluvastatin Are Associated With Dose-Dependent Reductions in Cirrhosis and Hepatocellular Carcinoma, Among Patients With Hepatitis C Virus: Results From ERCHIVES
Atorvastatin improves renal organic anion transporter 3 and renal function in gentamicin-induced nephrotoxicity in rats